Asia Pacific tissue banking market will grow by 9.6% annually with a total addressable market cap of $85.41 billion over 2021-2030 owing to the increasing demand for regenerative medicines and advancements in tissue preservation and in-house sample testing, an increasing number of biobanks across the globe, and the advancements in the medical drug discovery and biopharmaceuticals industry.
Highlighted with 31 tables and 59 figures, this 118-page report “Asia Pacific Tissue Banking Market 2020-2030 by Offering (Equipment, Accessories & Consumables, Services), Application (Therapeutics, Medical Research, Cosmetics), Tissue Type (Cardiovascular, Corneal, Lung, Kidney, Bone, Skin), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific tissue banking market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific tissue banking market in every aspect of the classification from perspectives of Offering, Application, Tissue Type, End User, and Country.
Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Equipment
o Cryopreservation Equipment
o Thawing Equipment
o Quality Control Equipment
o Labeling and Coding Equipment
o Alarming and Monitoring Systems
o Other Equipment
• Accessories and Consumables
• Services
o Screening
o Processing
o Tissue Retrieval
o Testing
o Storage and Preservation
o Other Services
Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Therapeutics
• Medical Research
• Cosmetics
• Other Applications
Based on Tissue Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Cardiovascular Tissue
• Corneal Tissue
• Lungs Tissue
• Kidney Tissue
• Bone Tissue
• Skin Tissue
• Brain & Spinal Cord
• Others Tissue Types
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Biobanks
• Hospitals and Clinics
• Research and Academic Institutes
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Offering, Application, and Tissue Type over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
AMS Biotechnology Ltd.
Avantor Inc. (VWR International)
Beckman Coulter, Inc.
Bio-Rad Laboratories Inc.
Bluechiip Limited
Brooks Lifesciences (Brooks Automation Inc.)
Custom Biogenic Systems, Inc.
Eppendorf AG
Hamilton Company
Merck KGaA
Organ Recovery Systems, Inc.
PHC Holdings Corporation
Sartorius AG
Taylor-Wharton International LLC
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36
3 Segmentation of Asia Pacific Market by Offering 40
3.1 Market Overview by Offering 40
3.2 Equipment 42
3.2.1 Cryopreservation Equipment 44
3.2.2 Thawing Equipment 45
3.2.3 Quality Control Equipment 46
3.2.4 Labeling and Coding Equipment 47
3.2.5 Alarming and Monitoring Systems 48
3.2.6 Other Equipment 49
3.3 Accessories and Consumables 50
3.4 Services 51
3.4.1 Screening 53
3.4.2 Processing 54
3.4.3 Tissue Retrieval 55
3.4.4 Testing 56
3.4.5 Storage and Preservation 57
3.4.6 Other Services 58
4 Segmentation of Asia Pacific Market by Application 59
4.1 Market Overview by Application 59
4.2 Therapeutics 61
4.3 Medical Research 62
4.4 Cosmetics 63
4.5 Other Applications 64
5 Segmentation of Asia Pacific Market by Tissue Type 65
5.1 Market Overview by Tissue Type 65
5.2 Cardiovascular Tissue 67
5.3 Corneal Tissue 68
5.4 Lungs Tissue 69
5.5 Kidney Tissue 70
5.6 Bone Tissue 71
5.7 Skin Tissue 72
5.8 Brain & Spinal Cord 73
5.9 Others Tissue Types 74
6 Segmentation of Asia Pacific Market by End User 75
6.1 Market Overview by End User 75
6.2 Biobanks 77
6.3 Hospitals and Clinics 78
6.4 Research and Academic Institutes 79
6.5 Other End Users 80
7 Asia-Pacific Market 2019-2030 by Country 81
7.1 Overview of Asia-Pacific Market 81
7.2 Japan 84
7.3 China 87
7.4 Australia 89
7.5 India 92
7.6 South Korea 94
7.7 Rest of APAC Region 96
8 Competitive Landscape 98
8.1 Overview of Key Vendors 98
8.2 New Product Launch, Partnership, Investment, and M&A 101
8.3 Company Profiles 102
AMS Biotechnology Ltd. 102
Avantor Inc. (VWR International) 104
Beckman Coulter, Inc. 105
Bio-Rad Laboratories Inc. 106
Bluechiip Limited 107
Brooks Lifesciences (Brooks Automation Inc.) 108
Custom Biogenic Systems, Inc. 109
Eppendorf AG 110
Hamilton Company 111
Merck KGaA 112
Organ Recovery Systems, Inc. 113
PHC Holdings Corporation 114
Sartorius AG 115
Taylor-Wharton International LLC 116
Thermo Fisher Scientific Inc. 117
RELATED REPORTS 118
Table 1. Snapshot of Asia Pacific Tissue Banking Market in Balanced Perspective, 2019-2030 17
Table 2. Growth Rate of World GDP, 2020-2022 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 28
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Tissue Banking Market 32
Table 5. Asia Pacific Tissue Banking Market by Offering, 2019-2030, $ mn 40
Table 6. Asia Pacific Tissue Banking Market: Equipment by Type, 2019-2030, $ mn 43
Table 7. Asia Pacific Tissue Banking Market: Services by Type, 2019-2030, $ mn 52
Table 8. Asia Pacific Tissue Banking Market by Application, 2019-2030, $ mn 59
Table 9. Asia Pacific Tissue Banking Market by Tissue Type, 2019-2030, $ mn 65
Table 10. Asia Pacific Tissue Banking Market by End User, 2019-2030, $ mn 75
Table 11. APAC Tissue Banking Market by Country, 2019-2030, $ mn 82
Table 12. Japan Tissue Banking Market by Offering, 2019-2030, $ mn 86
Table 13. Japan Tissue Banking Market by Application, 2019-2030, $ mn 86
Table 14. Japan Tissue Banking Market by Tissue Type, 2019-2030, $ mn 86
Table 15. China Tissue Banking Market by Offering, 2019-2030, $ mn 88
Table 16. China Tissue Banking Market by Application, 2019-2030, $ mn 88
Table 17. China Tissue Banking Market by Tissue Type, 2019-2030, $ mn 88
Table 18. Australia Tissue Banking Market by Offering, 2019-2030, $ mn 90
Table 19. Australia Tissue Banking Market by Application, 2019-2030, $ mn 90
Table 20. Australia Tissue Banking Market by Tissue Type, 2019-2030, $ mn 90
Table 21. India Tissue Banking Market by Offering, 2019-2030, $ mn 93
Table 22. India Tissue Banking Market by Application, 2019-2030, $ mn 93
Table 23. India Tissue Banking Market by Tissue Type, 2019-2030, $ mn 93
Table 24. South Korea Tissue Banking Market by Offering, 2019-2030, $ mn 95
Table 25. South Korea Tissue Banking Market by Application, 2019-2030, $ mn 95
Table 26. South Korea Tissue Banking Market by Tissue Type, 2019-2030, $ mn 95
Table 27. Tissue Banking Market in Rest of APAC by Country/Region, 2019-2030, $ mn 97
Table 28. AMS Biotechnology Ltd.: Company Snapshot 102
Table 29. AMS Biotechnology Ltd.: Business Segmentation 102
Table 30. AMS Biotechnology Ltd.: Product Portfolio 103
Table 31. AMS Biotechnology Ltd.: Revenue, 2017-2019, $ mn 103
